Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE®...

16
page 1/16 Stability of VACUETTE ® Lithium Heparin Separator tubes with modified centrifugation conditions Background: Greiner-Bio-One, Austria has been selling plastic evacuated tubes (VACUETTE ® ) for venous blood collection since 1986. The anticoagulant heparin activates antithrombins, thus blocking the coagulation cascade and producing a whole blood/plasma sample making it ideal for rapid analysis and analysis of blood from patients on anticoagulant therapy. VACUETTE ® Lithium Heparin Separator tubes contain a barrier gel in the tube. The specific gravity of this material lies between the blood cells and plasma. During centrifugation the gel moves upwards providing a stable barrier separating the plasma from cells. Plasma may be aspirated directly from the collection tube, eliminating the need for manual transfer to another container for analysis. [1] Study Objective: In order to shorten turn-around-time (TAT), laboratory professionals very often centrifuge a variety of blood collection tubes under the same centrifuge settings. This study was carried out to compare two different centrifugation conditions including stability of analytes for 48 hours in order to improve laboratory efficiency by standardizing centrifugation conditions. [2,3] Study design and procedure: Venous blood was collected from 40 presumably healthy donors into four VACUETTE ® Lithium Heparin Separator tubes (456087, 13/100, 5 ml) using VACUETTE ® Safety Blood Collection Sets with Holder (item # 450085). Two different VACUETTE ® gel tubes (Sample A US P-Gel and Sample B European Gel) were included in this test. A discard tube was used to guarantee appropriate filling of the tubes. The order of collection was randomized. All tubes were inverted 8 times immediately after blood collection. Tubes were then centrifuged with a Rotanta 460R centrifuge from Hettich at two different centrifugation conditions (see Table 1). Table 1: Centrifugation Sample RCF (x g) Time Temp [°C] Sample A P-Gel 2200g 15 min 20 °C Sample A P-Gel 1800g 10 min 20 °C Sample B Gel 2200g 15 min 20 °C Sample B Gel 1800g 10 min 20 °C All sample tubes were analyzed for the components listed below at the initial time point within 2 hours of blood collection and after 48 hours on the Siemens Advia analyzer and Abbott Architect analyzer using accompanying reagents from the instrument manufacturers. Between measurements, the samples were stored in the refrigerator at 4-8 °C. The following parameters were measured: Alanine Aminotransferase (ALT) Alkaline Phosphatase (ALP) Aspartate Aminotransferase (AST) Beta-HCG Blood Urea Nitrogen (BUN) Calcium Chloride Cholesterol Cholinesterase (CHE) Creatinine

Transcript of Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE®...

Page 1: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

page 1/16

Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions

Background:

Greiner-Bio-One, Austria has been selling plastic evacuated tubes (VACUETTE®) for venous blood collection since 1986. The anticoagulant heparin activates antithrombins, thus blocking the coagulation cascade and producing a whole blood/plasma sample making it ideal for rapid analysis and analysis of blood from patients on anticoagulant therapy. VACUETTE® Lithium Heparin Separator tubes contain a barrier gel in the tube. The specific gravity of this material lies between the blood cells and plasma. During centrifugation the gel moves upwards providing a stable barrier separating the plasma from cells. Plasma may be aspirated directly from the collection tube, eliminating the need for manual transfer to another container for analysis. [1] Study Objective: In order to shorten turn-around-time (TAT), laboratory professionals very often centrifuge a variety of blood collection tubes under the same centrifuge settings. This study was carried out to compare two different centrifugation conditions including stability of analytes for 48 hours in order to improve laboratory efficiency by standardizing centrifugation conditions. [2,3] Study design and procedure:

Venous blood was collected from 40 presumably healthy donors into four VACUETTE® Lithium Heparin Separator tubes (456087, 13/100, 5 ml) using VACUETTE® Safety Blood Collection Sets with Holder (item # 450085). Two different VACUETTE® gel tubes (Sample A US P-Gel and Sample B European Gel) were included in this test. A discard tube was used to guarantee appropriate filling of the tubes. The order of collection was randomized. All tubes were inverted 8 times immediately after blood collection. Tubes were then centrifuged with a Rotanta 460R centrifuge from Hettich at two different centrifugation conditions (see Table 1). Table 1: Centrifugation

Sample RCF (x g) Time Temp [°C]

Sample A P-Gel

2200g 15 min 20 °C

Sample A P-Gel

1800g 10 min 20 °C

Sample B Gel

2200g 15 min 20 °C

Sample B Gel

1800g 10 min 20 °C

All sample tubes were analyzed for the components listed below at the initial time point within 2 hours of blood collection and after 48 hours on the Siemens Advia analyzer and Abbott Architect analyzer using accompanying reagents from the instrument manufacturers. Between measurements, the samples were stored in the refrigerator at 4-8 °C. The following parameters were measured:

Alanine Aminotransferase (ALT) Alkaline Phosphatase (ALP) Aspartate Aminotransferase (AST) Beta-HCG Blood Urea Nitrogen (BUN)

Calcium Chloride Cholesterol Cholinesterase (CHE) Creatinine

Page 2: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

page 2/16

Gamma Glutamyltransferase (GGT) Glucose Iron Lactate Dehydrogenase (LDH) Magnesium Phosphate Potassium Sodium Total Bilirubin Total Protein

Triglyceride Troponin I Thyroid stimulating hormone (TSH) Urea Uric acid Vitamin B12 Free Triiodthyronin (fT3) Free Thyroxin (fT4)

Results: Comparison analysis was performed at the initial time point and at 48 hours. Statistical evaluation was performed with the T-test (α = 0.05) using StatSoft, Version 9. Clinical evaluation was based on the allowed recommendation by the German Medical Association (RIILBÄK). [4] No clinically significant differences were observed for either gel type with the two centrifugation settings of 2200g for 15 minutes and 1800g for 10 minutes at the initial time point or after 48 hours. However, Glucose values were affected by decomposition in cells after 48 hours. The use of a glycolysis inhibitor to compensate for this biochemical process would have been beneficial. Outlier testing was performed and showed that donor sample 14 (Sample A) for Alkaline Phosphatase at 2200g for 15 min was an outlier and was, therefore, excluded from statistical analysis. For Lactate Dehydrogenase, an analysis error occurred with donor sample 23 at the centrifugation setting of 2200g for 15 minutes at 48 hours (Sample B); donor sample 34 at 1800g for 10 min (Sample B) and donor sample 36 at 1800g for 10 min (Sample B) at the initial time point and 48 hours, all of which were excluded from statistical analysis. Conclusion:

In this trial, the stability of the biochemical analytes was demonstrated when using the centrifugation conditions as tested (2200g for 15 min at 20°C as well as 1800g for 10 min at 20°C) for VACUETTE® Lithium Heparin Separator tubes to optimize TAT in routine laboratories. These centrifugation conditions for VACUETTE® Lithium Heparin Separator tubes showed comparable results for the biochemical parameters tested at the initial time point and at 48 hours. Differences in results were not clinically significant.

References:

[1] Instructions for Use. Evacuated Blood Collection System. For in vitro Diagnostic Use. Rev. 13. [2] O‘Keane M. P., Evaluation of three different specimen types (serum, plasma, lithium heparin and serum gel separator) for analysis of certain analytes: clinical significance of differences in results and efficiency in use. Clin. Chem. Labor. Med. (44), 5 662-668 [3] Thomas L., Laboratory and Diagnosis. Indication and Evaluation of Laboratory Results for Medical Diagnosis. 7th edition. TH-Books. [4] Guideline from the medical association in Germany for quality assurance of laboratory tests. German Medical Journal. Vol. 105, Issue 7. 2008.

Page 3: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

page 3/16

Alanine Aminotransferase (ALT, GPT) Reference range: 0-45 U/l Sample A 0h

Alanine Aminotransferase 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

40

45

50

[U/l]

GPT 2200_15_A GPT 1800_10_A

Sample B 0h

Alanine Aminotransferase 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

40

45

50

[U/l]

GPT 2200_15_B GPT 1800_10_B

Alkaline Phosphatase: Reference range: 30-120 U/l Sample A 0h

Alkaline Phosphatase 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

[U/l]

AP 2200_15_ A AP 1800_10_A

Sample B 0h

Alkaline Phosphatase 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

[U/l]

AP 2200_15_ B AP 1800_10_B

Sample A 48h

Alanine Aminotransferase 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

40

45

50

[U/l]

GPT 2200_15_A_48 GPT 1800_10_A_48

Sample B 48h

Alanine Aminotransferase 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

40

45

50

[U/l]

GPT 2200_15_B_48 GPT 1800_10_B_48

Sample A 48h

Alkaline Phosphatase 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

U/l

AP 2200_15_ A_48 AP 1800_10_A_48

Sample B 48h

Alkaline Phosphatase 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

[U/l]

AP 2200_15_ B_48 AP 1800_10_B_48

Page 4: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 4/16

Aspartate Aminotransferase (AST, GOT) Reference range: 0-35 U/l Sample A 0h

Aspartate Aminotransferase 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

60

70

[U/l]

GOT 2200_15_A GOT 1800_10_A

Sample B 0h

Aspartate Aminotransferase 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

60

70

GOT 2200_15_B GOT 1800_10_B

Beta-HCG Reference range: 0-0.1 mIE/ml Sample A 0h

Beta-HCG 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

[mlE

/ml]

HCG 2200_15_A HCG 1800_10_A

Sample B 0h

Beta-HCG 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

[mlE

/ml]

HCG 2200_15_B HCG 1800_10_B

Sample A 48h

Aspartate Aminotransferase 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

60

70

[U/l]

GOT 2200_15_A_48 GOT 1800_10_A_48

Sample B 48h

Aspartate Aminotransferase 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

60

70

GOT 2200_15_B_48 GOT 1800_10_B_48

Sample A 48h

Beta-HCG 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

[mlE

/ml]

HCG 2200_15_A_48 HCG 1800_10_A_48

Sample B 48h

Beta-HCG 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

[mlE

/ml]

HCG 2200_15_B_48 HCG 1800_10_B_48

Page 5: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 5/16

Blood Urea Nitrogen (BUN) Reference range: 7-23 mg/dl Sample A 0h

Blood Urea Nitrogen (BUN) 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

12

14

16

18

20

22

24

[mg

/dl]

BUN 2200_15_A BUN 1800_10_A

Sample B 0h

Blood Urea Nitrogen (BUN) 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

12

14

16

18

20

22

24

[mg

/dl]

BUN 2200_15_B BUN 1800_10_B

Calcium Reference range: 2.1-2.7 mmol/l Sample A 0h

Calcium 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,5

1,0

1,5

2,0

2,5

3,0

[mm

ol/l

]

Ca 2200_15_A Ca 1800_10_A

Sample B 0h

Calcium 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,5

1,0

1,5

2,0

2,5

3,0

[mm

ol/l

]

Ca 2200_15_B Ca 1800_10_B

Sample A 48h

Blood Urea Nitrogen (BUN) 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

12

14

16

18

20

22

24

mg

/dl

BUN 2200_15_A_48 BUN 1800_10_A_48

Sample B 48h

Blood Urea Nitrogen (BUN) 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

12

14

16

18

20

22

24

[mg

/dl]

BUN 2200_15_B_48 BUN 1800_10_B_48

Sample A 48h

Calcium 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,5

1,0

1,5

2,0

2,5

3,0

mm

ol/l

Ca 2200_15_A_48 Ca 1800_10_A_48

Sample B 48h

Calcium 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,5

1,0

1,5

2,0

2,5

3,0

[mm

ol/l

]

Ca 2200_15_B_48 Ca 1800_10_B_48

Page 6: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 6/16

Chloride Reference range: 95-105 mmol/l Sample A 0h

Chloride 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

[mm

ol/l

]

Cl 2200_15_A Cl 1800_10_A

Sample B 0h

Chloride 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

[mm

ol/l

]

Cl 2200_15_B Cl 1800_10_B

Cholesterol Reference range: 100-200 mg/dl Sample A 0h

Cholesterol 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

[mg

/dl]

Chol 2200_15_A Chol 1800_10_A

Sample B 0h

Cholesterol 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

[mg

/dl]

Chol 2200_15_B Chol 1800_10_B

Sample A 48h

Chloride 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

mm

ol/l

Cl 2200_15_A_48 Cl 1800_10_A_48

Sample B 48h

Chloride 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

[mm

ol/l

]

Cl 2200_15_B_48 Cl 1800_10_B_48

Sample A 48h

Cholesterol 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

mg

/dl

Chol 2200_15_A_48 Chol 1800_10_A_48

Sample B 48h

Cholesterol 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

[mg

/dl]

Chol 2200_15_B_48 Chol 1800_10_B_48

Page 7: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 7/16

Cholesterinesterase Reference range: 4.5-11.5 kU/l Sample A 0h

Cholinesterase 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

12

14

[kU

/l]

CHE 2200_15_A CHE 1800_10_A

Sample B 0h

Cholinesterase 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

12

14

[kU

/l]

CHE 2200_15_B CHE 1800_10_B

Creatinine Reference range male: 0.55-1.17 mg/dl Sample A 0h

Creatinine 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

[mg

/dl]

Crea 2200_15_A Crea 1800_10_A

Sample B 0h

Creatinine 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

[mg

/dl]

Crea 2200_15_B Crea 1800_10_B

Sample A 48h

Cholinesterase 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

12

14

[kU

/l]

CHE 2200_15_A_48 CHE 1800_10_A_48

Sample B 48h

Cholinesterase 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

12

14

[kU

/l]

CHE 2200_15_B_48 CHE 1800_10_B_48

Sample A 48h

Creatinine 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

mg

/dl

Crea 2200_15_A_48 Crea 1800_10_A_48

Sample B 48h

Creatinine 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

[mg

/dl]

Crea 2200_15_B_48 Crea 1800_10_B_48

Page 8: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 8/16

Gamma Glutamyltransferase (GGT) Reference range: 0- 55 U/l Sample A 0h

GGT 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

60

70

80

90

100

[U/l]

GGT 2200_15_A GGT 1800_10_A

Sample B 0h

GGT 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

60

70

80

90

100

[U/l]

GGT 2200_15_B GGT 1800_10_B

Glucose Reference range: 60-110 mg/dl Sample A 0h

Glucose 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

140

[mg

/dl]

Gluc 2200_15_A Gluc 1800_10_A

Sample B 0h

Glucose 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

140

[mg

/dl]

Gluc 2200_15_B Gluc 1800_10_B

Sample A 48h

GGT 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

60

70

80

90

100

U/l

GGT 2200_15_A_48 GGT 1800_10_A_48

Sample B 48h

GGT 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

60

70

80

90

100

[U/l]

GGT 2200_15_B_48 GGT 1800_10_B_48

Sample A 48h

Glucose 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

140

[mg

/dl]

Gluc 2200_15_A_48 Gluc 1800_10_A_48

Sample B 48h

Glucose 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

140

[mg

/dl]

Gluc 2200_15_B_48 Gluc 1800_10_B_48

Page 9: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 9/16

Iron Reference range: 14.3-32.2 µmol/l Sample A 0h

Iron 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

[µmol/l]

Fe 2200_15_A Fe 1800_10_A

Sample B 0h

Iron 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

[µmol/l]

Fe 2200_15_B Fe 1800_10_B

Lactate Dehydrogenase Reference range: 0-248 U/l Sample A 0h

LDH 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

400

[U/l]

LDH 2200_15_A LDH 1800_10_A

Sample B 0h

LDH 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

400

[U/l]

LDH 2200_15_B LDH 1800_10_B

Sample A 48h

Iron 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

µmol/l

Fe 2200_15_A_48 Fe 1800_10_A_48

Sample B 48h

Iron 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

[µmol/l]

Fe 2200_15_B_48 Fe 1800_10_B_48

Sample A 48h

LDH 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

400

[U/l]

LDH 2200_15_A_48 LDH 1800_10_A_48

Sample B 48h

LDH 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

[U/l]

LDH 2200_15_B_48 LDH 1800_10_B_48

Page 10: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 10/16

Magnesium Reference range: 0.7-1.0 mmol/l Sample A 0h

Magnesium 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

[mm

ol/l

]

Mg 2200_15_A Mg 1800_10_A

Sample B 0h

Magnesium 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

[mm

ol/l

]

Mg 2200_15_B Mg 1800_10_B

Phosphate Reference range: 0.77-1.45 mmol/l Sample A 0h

Phosphate 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

[mm

ol/l

]

P 2200_15_A P 1800_10_A

Sample B 0h

Phosphate 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

[mm

ol/l

]

P 2200_15_B P 1800_10_B

Sample A 48h

Magnesium 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

[mm

ol/l

]

Mg 2200_15_A_48 Mg 1800_10_A_48

Sample B 48h

Magnesium 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

Mg 2200_15_B_48 Mg 1800_10_B_48

Sample A 48h

Phosphate 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

[mm

ol/l

]

P 2200_15_A_48 P 1800_10_A_48

Sample B 48h

Phosphate 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

[mm

ol/l

]

P 2200_15_B_48 P 1800_10_B_48

Page 11: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 11/16

Potassium Reference range: 3.5-5.3 mmol/l Sample A 0h

Potassium 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

1

2

3

4

5

6

[mm

ol/l

]

K 2200_15_A K 1800_10_A

Sample B 0h

Potassium 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

1

2

3

4

5

6

[mm

ol/l

]

K 2200_15_B K 1800_10_B

Sodium Reference range: 135-150 mmol/l Sample A 0h

Sodium 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

140

160

180

[mm

ol/l

]

Na 2200_15_A Na 1800_10_A

Sample B 0h

Sodium 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

140

160

180

[mm

ol/l

]

Na 2200_15_B Na 1800_10_B

Sample A 48h

Potassium 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

1

2

3

4

5

6

[mm

ol/l

]

K 2200_15_A_48 K 1800_10_A_48

Sample B 48h

Potassium 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

1

2

3

4

5

6

[mm

ol/l

]

K 2200_15_B_48 K 1800_10_B_48

Sample A 48h

Sodium 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

140

160

180

[mm

ol/l

]

Na 2200_15_A_48 Na 1800_10_A_48

Sample B 48h

Sodium 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

20

40

60

80

100

120

140

160

180

[mm

ol/l

]

Na 2200_15_B_48 Na 1800_10_B_48

Page 12: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 12/16

Total Bilirubin Reference range: 0.1-1.2 mg/dl Sample A 0h

Total Bilirubin 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

[mg

/dl]

TBili 2200_15_A TBili 1800_10_A

Sample B 0h

Total Bilirubin 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

[mg

/dl]

TBili 2200_15_B TBili 1800_10_B

Total Protein Reference range: 6-8 g/l Sample A 0h

Total Protein 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

[g/l]

TP 2200_15_A TP 1800_10_A

Sample B 0h

Total Protein 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

[g/l]

TP 2200_15_B TP 1800_10_B

Sample A 48h

Total Bilirubin 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

[mm

ol/l

]

TBil i 2200_15_A_48 TBili 1800_10_A_48

Sample B 48h

Total Bil irubin 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

1,8

2,0

[mm

ol/l

]

TBili 2200_15_B_48 TBili 1800_10_B_48

Sample A 48h

Total Protein 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

[g/l]

TP 2200_15_A_48 TP 1800_10_A_48

Sample B 48h

Total Protein 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

[g/l]

TP 2200_15_B_48 TP 1800_10_B_48

Page 13: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 13/16

Triglyceride Reference range: 25-180 mg/dl Sample A 0h

Triglyceride 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

[mg

/dl]

Tri 2200_15_A Tri 1800_10_A

Sample B 0h

Triglyceride 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

[mg

/dl]

Tri 2200_15_B Tri 1800_10_B

Troponin I Reference range: 0-0.028 ng/ml Sample A 0h

Troponin I 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,000

0,005

0,010

0,015

0,020

0,025

0,030

[ng

/ml]

Trop 2200_15_A Trop 1800_10_A

Sample B 0h

Troponin I 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,000

0,005

0,010

0,015

0,020

0,025

0,030

[ng

/ml]

Trop 2200_15_B Trop 1800_10_B

Sample A 48h

Triglyceride 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

[mg

/dl]

Tri 2200_15_A_48 Tri 1800_10_A_48

Sample B 48h

Triglyceride 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

50

100

150

200

250

300

350

[mg

/dl]

Tri 2200_15_B_48 Tri 1800_10_B_48

Sample A 48h

Troponin I 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,000

0,005

0,010

0,015

0,020

0,025

0,030

[ng

/ml]

Trop 2200_15_A_48 Trop 1800_10_A_48

Sample B 48h

Troponin I 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,000

0,005

0,010

0,015

0,020

0,025

0,030

[ng

/ml]

Trop 2200_15_B_48 Trop 1800_10_B_48

Page 14: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 14/16

Thyroid stimulating hormone (TSH) Reference range: 0.47-3.5 µU/ml Sample A 0h

TSH 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

1

2

3

4

5

6

7

[µU/m

l]

TSH 2200_15_A TSH 1800_10_A

Sample B 0h

TSH 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

1

2

3

4

5

6

7

[µU/m

l]

TSH 2200_15_B TSH 1800_10_B

Urea Reference range: 15-50 mg/dl Sample A 0h

Urea 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

5

10

15

20

25

30

35

40

45

50

[mg

/dl]

U 2200_15_A U 1800_10_A

Sample B 0h

Urea 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

[mg

/dl]

U 2200_15_B U 1800_10_B

Sample A 48h

TSH 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

1

2

3

4

5

6

7

[µU/m

l]

TSH 2200_15_A_48 TSH 1800_10_A_48

Sample B 48h

TSH 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

1

2

3

4

5

6

7

[µU/m

l]

TSH 2200_15_B_48 TSH 1800_10_B_48

Sample A 48h

Urea 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

[mg

/dl]

U 2200_15_A_48 U 1800_10_A_48

Sample B 48h

Urea 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

10

20

30

40

50

[mg

/dl]

U 2200_15_B_48 U 1800_10_B_48

Page 15: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 15/16

Uric acid Reference range male: 3.5-7.0 mg/dl Sample A 0h

Uric Acid 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

[mg

/dl]

UA 2200_15_A UA 1800_10_A

Sample B 0h

Uric Acid 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

[mg

/dl]

UA 2200_15_B UA 1800_10_B

Vitamin B12 Reference range male: 214-864 ng/l Reference range female: 182-820 ng/l Sample A 0h

Vitamin B12 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

100

200

300

400

500

600

700

800

900

[pg

/ml]

Vit B 2200_15_A Vit B 1800_10_A

Sample B 0h

Vitamin B12 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

100

200

300

400

500

600

700

800

900

[pg

/ml]

Vit B 2200_15_B Vit B 1800_10_B

Sample A 48h

Uric Acid 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

[mg

/dl]

UA 2200_15_A_48 UA 1800_10_A_48

Sample B 48h

Uric Acid 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

2

4

6

8

10

[mg

/dl]

UA 2200_15_B_48 UA 1800_10_B_48

Sample A 48h

Vitamin B12 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

100

200

300

400

500

600

700

800

900

[pg

/ml]

Vit B 2200_15_A_48 Vit B 1800_10_A_48

Sample B 48h

Vitamin B12 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410

100

200

300

400

500

600

700

800

900

[pg

/ml]

Vit B 2200_15_B_48 Vit B 1800_10_B_48

Page 16: Stability of VACUETTE Lithium Heparin Separator tubes with ... · page 1/16 Stability of VACUETTE® Lithium Heparin Separator tubes with modified centrifugation conditions Background:

RO04 page 16/16

Free Triiodthyronin (fT3)

Reference range: 1.39-4.14 pg/ml Sample A 0h

fT3 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,5

1,0

1,5

2,0

2,5

3,0

3,5

4,0

[pg

/ml]

fT3 2200_15_A fT3 1800_10_A

Sample B 0h

fT3 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,5

1,0

1,5

2,0

2,5

3,0

3,5

4,0

[pg

/ml]

fT3 2200_15_B FT3 1800_10_B

Free Thyroxin (fT4)

Reference range: 0.75-2.0 ng/dl Sample A 0h

fT4 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

[ng

/dl]

fT4 2200_15_A fT4 1800_10_A

Sample B 0h

fT4 0h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

[ng

/dl]

fT4 2200_15_B fT4 1800_10_B

Sample A 48h

fT3 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,5

1,0

1,5

2,0

2,5

3,0

3,5

4,0

[pg

/ml]

fT3 2200_15_A_48 fT3 1800_10_A_48

Sample B 48h

fT3 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,5

1,0

1,5

2,0

2,5

3,0

3,5

4,0

[pg

/ml]

fT3 2200_15_B_48 FT3 1800_10_B_48

Sample A 48h

fT4 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

[ng

/dl]

fT4 2200_15_A_48 fT4 1800_10_A_48

Sample B 48h

fT4 48h

1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 33 35 37 39 410,0

0,2

0,4

0,6

0,8

1,0

1,2

1,4

1,6

[ng

/dl]

fT4 2200_15_B_48 fT4 1800_10_B_48